Providing funding in 93 countries, UNITAID today finances drugs for three-quarters of the children around the world who receive anti-retrovirals. Widespread coverage has been achieved through UNITAID’s influence on the price of life-saving drugs: it guarantees a market through long-term commitments to purchase high volumes of medicines and diagnostics – a commitment made possible by the sustainable and predictable funding of the “air tax.”